Sign In

Per Lundin

Co-Founder & Chief Operating Officer at Evox Therapeutics

Per Lundin is a highly educated individual with a diverse academic background in Neurochemistry, Business Administration, Economics, Biotechnology, Biochemistry, Immunology, Chemical Engineering, and Medical Science.

Throughout his career, Per Lundin has held various key positions in renowned organizations, showcasing his expertise and leadership skills.

He is a Co-Founder and Chief Operating Officer at Evox Therapeutics Ltd, where he plays a crucial role in the company's operations and strategic decisions.

Per Lundin has also served as a Non-Executive Director at CombiGene and IsletOne Therapeutics, demonstrating his involvement in the biotechnology and medical sectors.

His professional journey includes notable roles such as the European Law Firm Market Manager at Thomson Reuters, Co-Founder and CEO at IsletOne Therapeutics, Business Development Manager at Thomson Reuters, Patent Attorney at Zacco - 360° Intellectual Property, and Research Scientist at Apollo Life Sciences.

Per Lundin's vast experience spans across different industries, showcasing his ability to adapt and excel in diverse work environments.

Per Lundin
Add to my network

Location

Oxford, England, United Kingdom